AXM Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2017	FY 2005
Period Ending	Jun '18 Jun 30, 2018	Dec '17 Dec 31, 2017	Dec '05 Dec 31, 2005
Cash & Equivalents	1.66	2.17	0.09
Cash & Short-Term Investments	1.66	2.17	0.09
Cash Growth	-	2243.38%	-
Receivables	5.88	6.02	1.07
Inventory	29.93	31.64	2.29
Total Current Assets	38.06	39.83	4.06
Property, Plant & Equipment	62.93	56.97	7.56
Long-Term Investments	1.42	1.79	-
Long-Term Deferred Charges	-	5.83	-
Total Assets	102.41	104.43	13.73
Accounts Payable	11.9	19.66	-
Accrued Expenses	0.01	0.01	-
Short-Term Debt	27.94	22.4	-
Current Income Taxes Payable	0.06	1.24	-
Other Current Liabilities	14.55	15.05	-
Total Current Liabilities	54.45	58.36	9.64
Long-Term Debt	1.39	3.61	-
Total Liabilities	55.85	61.97	9.64
Common Stock	8.83	8.83	-
Retained Earnings	34.9	30.86	-
Comprehensive Income & Other	2.83	2.77	-
Shareholders' Equity	46.56	42.46	4.09
Total Liabilities & Equity	102.41	104.43	13.73
Total Debt	29.33	26.01	-
Net Cash (Debt)	-27.67	-23.84	-
Net Cash Per Share	-0.01	-0.00	-
Filing Date Shares Outstanding	5,300	5,300	-
Total Common Shares Outstanding	5,300	5,300	-
Working Capital	-16.39	-18.53	-
Book Value Per Share	0.01	0.01	-
Tangible Book Value	46.56	42.46	-
Tangible Book Value Per Share	0.01	0.01	-
Land	7.46	7.42	-
Buildings	21.71	19.04	-
Machinery	38.24	34.46	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.